Is Acerus Pharmaceuticals Corporation (ASP.TO) a Buy, Sell, or Hold?
TSX : ASP.TO
Acerus Pharmaceuticals Corporation
$0.36 CAD
$0 (0.0%)
- Volume
- 1.25K
- Average Volume
- 1.42K
- Market Capitalization
- $2.77M
- P/E Ratio
- -0.06
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.00
- Year Low
- $0.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.72
Company Overview
TSX
Edward Gudaitis
Drug Manufacturers - Specialty & Generic
Healthcare
ASP.TO
14
CA
CAD
Liquidity Metrics
-0.91
0.72
0.33
0.18
0.00
Sales & Valuation
-$4.13M
-0.48
-0.08
-0.08
-3.07
Profitability
-$4.61
-$35.46M
857.88%
818.22%
310.28%
-367.34%
P/E Metrics
-0.06
-0.01
-0.01
Analyst Price Target & Rating
0/5
1 Analysts
%
Financial Health Scores
-8.96
3/9
-$5.04M
$47.67M
$61.56M
-$23.89M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Chris Witty | Investor Relations |
| Edward Gudaitis | Pres, Chief Executive Officer & Director |
| Gavin Damstra | Senior Vice President of International Commercial |
| Hubert Tomasz Czerwinski | Pres of Acerus Pharmaceuticals SRL |
| Philippe Savard | Senior Vice President, Gen. Counsel & Corporation Sec. |
| Kevin Thomas Hickey | Senior Vice President of US Commercial |
| Naveed Manzoor | Interim Chief Financial Officer |
| Christopher Sorli | Chief Medical Officer |
Poll Results
No votes yet today — be the first to share your view!
About Acerus Pharmaceuticals Corporation (TSX:ASP.TO) Stock
Acerus Pharmaceuticals Corporation is a specialty pharmaceutical firm dedicated to the development, production, marketing, and distribution of medications for men's and women's health. Its marketed products include Natesto, a nasal gel used for testosterone replacement therapy in adult males diagnosed with hypogonadism, and Noctiva, a vasopressin analog indicated for the treatment of nocturia stemming from nocturnal polyuria in adults who awaken at least two times per night to void. The company is also developing a pipeline of products such as Lidbree, a short-acting lidocaine formulation delivered into the vaginal mucosal tissue using a proprietary device; Stendra, a PDE5 inhibitor for treating erectile dysfunction; Tefina, a clinical-stage therapy for female sexual dysfunction; and vario ... us Noctiva combination products, which are in pre-clinical development stages for conditions including benign prostatic hypertrophy, overactive bladder, and pediatric nocturnal enuresis. Furthermore, Acerus utilizes the TriVair technology platform for pulmonary and nasal dosing. Distribution of its products occurs via its salesforce in the United States and Canada, and through a network of international distributors. Founded in 2008, the company operated as Trimel Pharmaceuticals Corporation until changing its name to Acerus Pharmaceuticals Corporation in September 2015. It maintains its headquarters in Mississauga, Canada.
Frequently Asked Questions
-
What is the current Acerus Pharmaceuticals Corporation (ASP.TO) stock price?
-
Acerus Pharmaceuticals Corporation(TSX:ASP.TO) stock price is $0.36 in the last trading session. During the trading session, ASP.TO stock reached the peak price of $10.0 while $0.28 was the lowest point it dropped to. The percentage change in ASP.TO stock occurred in the recent session was 0.0% while the dollar amount for the price change in ASP.TO stock was $0.
-
ASP.TO's industry and sector of operation?
-
The TSX listed ASP.TO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of ASP.TO?
-
Chris Witty | Investor Relations
Edward Gudaitis | Pres, Chief Executive Officer & Director
Gavin Damstra | Senior Vice President of International Commercial
Hubert Tomasz Czerwinski | Pres of Acerus Pharmaceuticals SRL
Philippe Savard | Senior Vice President, Gen. Counsel & Corporation Sec. -
How many employees does ASP.TO have?
-
Number of ASP.TO employees currently stands at 14. ASP.TO operates from 7025 Langer Drive, Mississauga, ON L5N 0E8, CA.
-
Link for ASP.TO official website?
-
Official Website of ASP.TO is: https://www.aceruspharma.com
-
How do I contact ASP.TO?
-
ASP.TO could be contacted at phone #14167932740 and can also be accessed through its website. ASP.TO operates from 7025 Langer Drive, Mississauga, ON L5N 0E8, CA.
-
How many shares of ASP.TO are traded daily?
-
The average number of ASP.TO shares traded daily for last 3 months was 1.42K.
-
What is the market cap of ASP.TO currently?
-
The market value of ASP.TO currently stands at $2.77M with its latest stock price at $0.36